H-D-allo-Thr(tBu)-OH

H-D-allo-Thr(tBu)-OH is a chiral, amino-acid-derived building block corresponding to an allo-threonine stereochemical variant in which the side-chain hydroxyl is protected as a tert-butyl ether. The molecule is presented as the free carboxylic acid with an N-terminal hydrogen, enabling direct participation in peptide coupling workflows after conversion to an activated acid or after selective protection steps as required. The allo configuration at the α-carbon and the tert-butyl-protected hydroxyl establish defined stereochemical and orthogonal functional-group behavior, supporting controlled side-chain derivatization while preserving the amino acid backbone integrity. The presence of a tert-butyl ether also provides a predictable deprotection handle under acid-labile conditions, making the compound suitable as a protected threonine analog for downstream peptide and peptidomimetic synthesis.

1. Peptide Synthesis

H-D-allo-Thr(tBu)-OH supports peptide building-block construction where threonine side-chain functionality must be masked during coupling and then revealed for selective elaboration. The carboxylic acid and amino functionality enable formation of peptide bonds after appropriate activation, while the tert-butyl-protected hydroxyl prevents undesired O-acylation or cross-reactivity during amide bond formation. The allo stereochemistry can be leveraged to access stereochemically defined peptide analogs and to probe how epimeric side-chain orientation influences conformational preferences. After assembly, tert-butyl ether cleavage can regenerate the side-chain alcohol for subsequent phosphorylation-mimetic installation, glycosylation handle generation, or other hydroxyl-directed transformations, aligning with protected amino acid synthesis strategies used in peptide chemistry.

2. Side-Chain Functionalization

H-D-allo-Thr(tBu)-OH is suitable for side-chain functionalization workflows that require controlled exposure of a threonine hydroxyl group from an orthogonally protected intermediate. The tert-butyl ether functions as a temporary protecting group that can be removed to yield a free hydroxyl for targeted derivatization, including conversion to activated leaving groups, esterification, or incorporation into hydrogen-bonding motifs relevant to peptidomimetic design. The allo-threonine stereocenter provides a defined spatial relationship between the α-amino acid backbone and the side-chain oxygen, enabling stereochemically resolved analog series for structure-function investigations. Downstream use can include preparation of hydroxyl-bearing peptide fragments, intermediate formation for further coupling, and generation of functionalized amino acid derivatives for synthetic organic chemistry campaigns.

3. Peptidomimetics And SAR Studies

H-D-allo-Thr(tBu)-OH can be employed in peptidomimetic construction where stereodefined threonine analogs help tune molecular recognition features. The amino acid backbone and protected side-chain hydroxyl allow incorporation into constrained scaffolds while maintaining compatibility with common peptide coupling chemistries and post-assembly functional-group manipulations. The allo configuration may serve as a stereochemical probe in structure-activity relationship studies by enabling systematic comparison against other threonine stereoisomers or side-chain-protected variants. Deprotection of the tert-butyl ether can provide access to hydroxyl-reactive intermediates used to introduce polar groups, linkers, or bioisosteres, supporting iterative medicinal-chemistry style synthesis of amino acid-based analog libraries.

4. Chemical Biology Labeling

H-D-allo-Thr(tBu)-OH is applicable to chemical biology workflows that require controlled generation of a reactive hydroxyl handle for conjugation chemistry. The tert-butyl-protected hydroxyl can be carried through peptide or ligand assembly steps without participating in side reactions, then deprotected to yield a free alcohol suitable for subsequent functionalization such as linker attachment or affinity-tag incorporation. The defined stereochemistry of the allo-threonine residue helps maintain consistent three-dimensional presentation of the hydroxyl group within the conjugate, which can be relevant for binding-site mimicry and reagent reproducibility. Resulting derivatives can serve as building blocks for labeled biomolecule fragments, affinity probes, or reagent intermediates used in biochemical research and molecular recognition studies.

5. Pharmaceutical Intermediate Preparation

H-D-allo-Thr(tBu)-OH is suitable as a process-chemistry intermediate for manufacturing routes that require threonine-derived, side-chain-protected amino acid units. The combination of a free carboxylic acid and a tert-butyl-protected hydroxyl supports stepwise protection/deprotection logic, enabling conversion to activated forms for peptide fragment assembly or to downstream functionalized intermediates under controlled conditions. The allo stereocenter can be used to ensure stereochemical fidelity in synthetic sequences where epimeric purity and stereodefined analog generation are required for consistent downstream properties. Industrial use can extend to fine chemical synthesis of protected amino acid derivatives and to preparation of defined peptide-building blocks for larger-scale peptide or peptidomimetic manufacturing programs.

1. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

2. TMEM16F and dynamins control expansive plasma membrane reservoirs

3. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

4. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

5. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients